These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 25621137)

  • 1. Efficacy and safety of switching to insulin glulisine from other rapid-acting insulin analogs in children with type 1 diabetes.
    Urakami T; Kuwabara R; Habu M; Okuno M; Suzuki J; Takahashi S
    J Diabetes Investig; 2015 Jan; 6(1):87-90. PubMed ID: 25621137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin glulisine for continuous subcutaneous insulin infusion in pediatric type 1 diabetes.
    Urakami T; Mine Y; Aoki M; Okuno M; Suzuki J
    Pediatr Int; 2017 May; 59(5):647-649. PubMed ID: 28544684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and Safety of Rapid-Acting Insulin Analogs in Special Populations with Type 1 Diabetes or Gestational Diabetes: Systematic Review and Meta-Analysis.
    Nørgaard K; Sukumar N; Rafnsson SB; Saravanan P
    Diabetes Ther; 2018 Jun; 9(3):891-917. PubMed ID: 29623593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fields of application of continuous subcutaneous insulin infusion in the treatment of diabetes and implications in the use of rapid-acting insulin analogues.
    Pitocco D; Rizzi A; Scavone G; Tanese L; Zaccardi F; Manto A; Ghirlanda G
    Minerva Endocrinol; 2013 Sep; 38(3):321-8. PubMed ID: 24126552
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Switching to multiple daily injection therapy with glulisine improves glycaemic control, vascular damage and treatment satisfaction in basal insulin glargine-injected diabetic patients.
    Yanagisawa K; Ashihara J; Obara S; Wada N; Takeuchi M; Nishino Y; Maeda S; Ishibashi Y; Yamagishi S
    Diabetes Metab Res Rev; 2014 Nov; 30(8):693-700. PubMed ID: 24639403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety of insulin glulisine when given by continuous subcutaneous infusion using an external pump in patients with type 1 diabetes.
    Hoogma RP; Schumicki D
    Horm Metab Res; 2006 Jun; 38(6):429-33. PubMed ID: 16823727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of insulins glulisine and aspart on postprandial glycemia after a high-glycemic index meal in children with type 1 diabetes.
    Dzygalo K; Szypowska A
    Eur J Endocrinol; 2014 Apr; 170(4):539-45. PubMed ID: 24412929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of rapid-acting insulin analogues insulin glulisine and insulin aspart on postprandial glycemic excursion with single bout of exercise in patients with type 2 diabetes.
    Tanaka N; Hiura Y
    Endocr J; 2015; 62(5):411-6. PubMed ID: 25739586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of insulin glulisine to improve glycemic control in children with diabetes mellitus.
    Lih A; Hibbert E; Wong T; Girgis CM; Garg N; Carter JN
    Diabetes Metab Syndr Obes; 2010 Nov; 3():403-12. PubMed ID: 21437110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Humalog Mix 25 in patients with type 2 diabetes which do not achieve acceptable glycemic control with oral agents: results from a phase III, randomized, parallel study.
    Tîrgovişte CI; Străchinariu R; Farcaşiu E; Milicevic Z; Teodorescu G
    Rom J Intern Med; 2003; 41(2):153-62. PubMed ID: 15526500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin glulisine: an evaluation of its pharmacodynamic properties and clinical application.
    Helms KL; Kelley KW
    Ann Pharmacother; 2009 Apr; 43(4):658-68. PubMed ID: 19336657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Addressing hyperglycemia from hospital admission to discharge.
    Moghissi ES
    Curr Med Res Opin; 2010 Mar; 26(3):589-98. PubMed ID: 20078323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Benefits of continuous subcutaneous insulin infusion in type 1 diabetes previously treated with multiple daily injections with once-daily glargine and pre-meal analogues.
    Torres I; Ortego J; Valencia I; García-Palacios MV; Aguilar-Diosdado M
    Exp Clin Endocrinol Diabetes; 2009 Sep; 117(8):378-85. PubMed ID: 19629931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized, controlled trial comparing twice-a-day insulin glargine mixed with rapid-acting insulin analogs versus standard neutral protamine Hagedorn (NPH) therapy in newly diagnosed type 1 diabetes.
    Hassan K; Rodriguez LM; Johnson SE; Tadlock S; Heptulla RA
    Pediatrics; 2008 Mar; 121(3):e466-72. PubMed ID: 18299307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of rapid-acting insulin analogs on overall glycemic control in type 1 and type 2 diabetes mellitus.
    Ristic S; Bates PC
    Diabetes Technol Ther; 2003; 5(1):57-66. PubMed ID: 12725708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized study of basal-bolus insulin therapy in the inpatient management of patients with type 2 diabetes (RABBIT 2 trial).
    Umpierrez GE; Smiley D; Zisman A; Prieto LM; Palacio A; Ceron M; Puig A; Mejia R
    Diabetes Care; 2007 Sep; 30(9):2181-6. PubMed ID: 17513708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sustained efficacy of continuous subcutaneous insulin infusion in type 1 diabetes subjects with recurrent non-severe and severe hypoglycemia and hypoglycemia unawareness: a pilot study.
    Giménez M; Lara M; Conget I
    Diabetes Technol Ther; 2010 Jul; 12(7):517-21. PubMed ID: 20597825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Introducing a simplified approach to insulin therapy in type 2 diabetes: a comparison of two single-dose regimens of insulin glulisine plus insulin glargine and oral antidiabetic drugs.
    Lankisch MR; Ferlinz KC; Leahy JL; Scherbaum WA;
    Diabetes Obes Metab; 2008 Dec; 10(12):1178-85. PubMed ID: 19040645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advantage of premeal-injected insulin glulisine compared with regular human insulin in subjects with type 1 diabetes.
    Rave K; Klein O; Frick AD; Becker RH
    Diabetes Care; 2006 Aug; 29(8):1812-7. PubMed ID: 16873785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of rapid-acting insulin analogues in the treatment of patients with type 1 and type 2 diabetes mellitus: insulin pump therapy versus multiple daily injections.
    Bode BW
    Clin Ther; 2007; 29 Suppl D():S135-44. PubMed ID: 18191065
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.